Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    L01 ANTINEOPLASTIC AGENTS
      L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
        L01FC CD38 (Clusters of Differentiation 38) inhibitors
          L01FC01 Daratumumab
            D10777  Daratumumab (USAN) <JP/US>

USP drug classification [BR:br08302]
  Antineoplastics
    Monoclonal Antibody/Antibody-Drug Conjugate
      Daratumumab
        D10777  Daratumumab (USAN)

Therapeutic category of drugs in Japan [BR:br08301]
  4  Agents affecting cellular function
    42  Antineoplastics
      429  Miscellaneous
        4291  Other Antitumors
          D10777  Daratumumab (USAN); Daratumumab (genetical recombination) (JAN)

Target-based classification of drugs [BR:br08310]
  Enzymes
    Hydrolases (EC3)
      ADP-ribosyl cyclase [EC:3.2.2.6]
        CD38 [HSA:952] [KO:K01242]
          D10777  Daratumumab (USAN) <JP/US>

New drug approvals in the USA [br08319.html]
  D10777

New drug approvals in Europe [br08329.html]
  D10777

New drug approvals in Japan [br08318.html]
  D10777

New drug approvals in the USA, Europe and Japan [br08328.html]
  D10777